Advice
Recommended for restricted use within NHS Scotland.
RECOMMENDATION.
Risperdal Consta may be considered as a treatment option for patients who require an atypical antipsychotic and for whom depot injection is the preferred route of administration. Its use should be under the overall supervision of a consultant psychiatrist.
Download detailed advice18KB (PDF)
Medicine details
- Medicine name:
- Risperidone (Risperdal Consta®)
- SMC ID:
- 22/02
- Indication:
- Schizophrenic psychoses
- Pharmaceutical company
- Janssen-Cilag Ltd
- BNF chapter
- Central nervous system
- Submission type
- Full
- Status
- Restricted
- Date advice published
- 06 December 2002